Axicabtagene ciloleucel
Gilead,Daiichi Sankyo
[]
 it would be hard to justify giving chemotherapy as 1st line therapy post-car-t failure for most pts given low orrs. outside of a trial my approach is polabr &amp; if in cr --&gt; allohct. but if a pt happens to be chemosensitive we should absolutely take them for autohct.
Assistant Professor of Medicine @UWCarbone | Lymphoma, Cellular Immunotherapies & BMT | Runner ????? Mother of 2 amazing. silly kids